These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26855348)

  • 1. How Low Can You Go?: Implications of the Systolic Blood Pressure Intervention Trial for Hypertension Management.
    Dennison Himmelfarb CR; Hayman LL; Nelson Worel J
    J Cardiovasc Nurs; 2016; 31(2):99-100. PubMed ID: 26855348
    [No Abstract]   [Full Text] [Related]  

  • 2. Unattended Blood Pressure Measurements in the Systolic Blood Pressure Intervention Trial: Implications for Entry and Achieved Blood Pressure Values Compared With Other Trials.
    Kjeldsen SE; Lund-Johansen P; Nilsson PM; Mancia G
    Hypertension; 2016 May; 67(5):808-12. PubMed ID: 27001295
    [No Abstract]   [Full Text] [Related]  

  • 3. Review of the Systolic Blood Pressure Intervention Trial for Hypertension Management: How Low to Go for Patients With Stroke?
    Silver B; Anderson CS
    Stroke; 2016 Jun; 47(6):1692-4. PubMed ID: 27094994
    [No Abstract]   [Full Text] [Related]  

  • 4. Brachial-brachial index of systolic blood pressure in the patients under anti-hypertensive therapy.
    Sun H; Li P; Su H; Wang W; Wang J; Hu W; Li J; Liu Y; Cheng X
    Int J Cardiol; 2014 Jul; 174(3):802-4. PubMed ID: 24814541
    [No Abstract]   [Full Text] [Related]  

  • 5. The detection rates of inter-arm systolic blood pressure difference vary with blood pressure levels in hypertensive patients under antihypertensive therapy.
    Sun H; Li P; Su H; Wang J; Hu W; Li J; Liu Y; Cheng X
    Int J Cardiol; 2014 Apr; 172(3):e419-20. PubMed ID: 24444483
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant Hypertension: Insights on Evaluation and Management in the Post-SPRINT (Systolic Blood Pressure Intervention Trial) Era.
    Townsend RR; Epstein M
    Hypertension; 2016 Nov; 68(5):1073-1080. PubMed ID: 27600177
    [No Abstract]   [Full Text] [Related]  

  • 8. [New guidelines for hypertension management in 2013].
    Xhignesse P; Krzesinski JM
    Rev Med Liege; 2013 Oct; 68(10):511-20. PubMed ID: 24298725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of candesartan cilexetil with hydrochlorothiazide on blood pressure and ST-segment depression in patients with arterial hypertension].
    Uen S; Un I; Fimmers R; Vetter H; Mengden T
    Dtsch Med Wochenschr; 2007 Jan; 132(3):81-6. PubMed ID: 17219340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice Guidelines for Hypertension.
    Zeigler D; Patel A; Zeigler C
    S D Med; 2017 Spec; Spec No():43-46. PubMed ID: 28817862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical decision support to improve blood pressure control in hemodialysis patients: a nonrandomized controlled trial.
    Thompson S; Hemmelgarn B; Wiebe N; Majumdar S; Klarenbach S; Jindal K; Manns B; Mortis G; Campbell P; Tonelli M;
    J Nephrol; 2012; 25(6):944-53. PubMed ID: 23147684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive treatment of elderly patients with isolated systolic hypertension].
    Uzunian TG; Boroian RG; Zelvian PA
    Kardiologiia; 2008; 48(12):59-64. PubMed ID: 19076096
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the Evidence Provided by the SPRINT Trial Solid Enough to Support a Systolic Blood Pressure Threshold of 120 mmHg?
    García-Zamora S; Botto F
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):520-521. PubMed ID: 30971377
    [No Abstract]   [Full Text] [Related]  

  • 14. Lessons from recent hypertension trials: how low to lower blood pressure.
    Gifford RW
    South Med J; 2000 May; 93(5):528-30. PubMed ID: 10832958
    [No Abstract]   [Full Text] [Related]  

  • 15. A prospective study on pulse wave velocity (PWV) and response to anti-hypertensive treatments: PWV determines BP control.
    Zheng M; Huo Y; Wang X; Xu X; Qin X; Tang G; Xing H; Fan F; Li J; Zhang Y; Wang B; Xu X; Yang X; Chen Y; Qian G
    Int J Cardiol; 2015 Jan; 178():226-31. PubMed ID: 25464260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension treatment in the new millennium: the importance of controlling systolic blood pressure and the pulse pressure.
    McMahon FG; Frohlich E
    J La State Med Soc; 2000 Jun; 152(6):293-5. PubMed ID: 10935369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of blood pressure variability: a new strategy for the treatment of hypertension.
    Su DF; Miao CY
    Trends Pharmacol Sci; 2005 Aug; 26(8):388-90. PubMed ID: 15990175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated Systolic Hypertension in Young People Is Not Spurious and Should Be Treated: Con Side of the Argument.
    Lurbe E; Redon J
    Hypertension; 2016 Aug; 68(2):276-80. PubMed ID: 27324227
    [No Abstract]   [Full Text] [Related]  

  • 19. Contemporary Management and Control of Uncomplicated Hypertension in Canada: Insight From the Primary Care Audit of Global Risk Management (PARADIGM) Study.
    Gupta M; Szmitko P; Singh N; Tsigoulis M; Kajil M; Stone J
    Can J Cardiol; 2015 May; 31(5):664-70. PubMed ID: 25936492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and stroke: an appraisal of the evidence and implications for clinical management.
    Lackland DT; Voeks JH; Boan AD
    Expert Rev Cardiovasc Ther; 2016; 14(5):609-16. PubMed ID: 26782835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.